Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
Onco PanScan™
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Genetron Health
Type:
CE Marked
Related tests:
‹
AYVAKIT® CDx test
FusionScan Plus
HCCscreen™
Lung Cancer 8-Gene Kit
Seq-MRD® assay
AYVAKIT® CDx test
FusionScan Plus
HCCscreen™
Lung Cancer 8-Gene Kit
Seq-MRD® assay
›
Details
Evidence
News
Onco PanScan™ detects MSI through next generation sequencing (NGS).
Cancer:
Solid Tumor
Gene:
MSI (Microsatellite instability)
MSI (Microsatellite instability)
Method:
Next-Generation Sequencing (NGS)
Approvals
Date
Cancer
Gene
Biomarker
Drug
Approved by
11/04/2021
Solid Tumor
-
-
CE Marked
Approvals
Date
Cancer
Gene
Drug
By
11/04/21
ST
-
CE
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.